Connaughton Bernadette
SEC insider (Form 3/4/5 filer). CIK 0001662521. Director at HALOZYME THERAPEUTICS, INC. (HALO) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Connaughton Bernadette has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Director
- Editas Medicine, Inc. (EDIT): Director
Connaughton Bernadette
CIK: 0001662521
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 10, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect1.6K shares at avg. $102.80$167K - Jul 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect625 shares at avg. $77.21$48K - Jul 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect1K shares at avg. $76.39$76K - Jun 17, 2026EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
51.7K shares- - Jun 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect1.6K shares at avg. $66.21$108K - May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect3.8K shares- - May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirectOption to Purchase Common Stock
6K shares- - May 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect1.6K shares at avg. $63.48$103K - Jan 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect2K shares at avg. $70.25$141K - Dec 1, 2025HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect829 shares at avg. $71.60$59K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  HALO HALOZYME THERAPEUTICS, INC. | Sale | 1,626 | $102.80 | $167,153 | Direct |
| Jul 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 625 | $77.21 | $48,256 | Direct |
| Jul 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 1,000 | $76.39 | $76,395 | Direct |
| Jun 17, 2026 |  EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 51,700 | - | - | Direct |
| Jun 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 1,625 | $66.21 | $107,591 | Direct |
| May 5, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award | 3,796 | - | $0 | Direct |
| May 5, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Award Option to Purchase Common Stock | 6,040 | - | - | Direct |
| May 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 1,625 | $63.48 | $103,155 | Direct |
| Jan 5, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 2,000 | $70.25 | $140,500 | Direct |
| Dec 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 829 | $71.60 | $59,356 | Direct |
1-10 of 18 transactions